| Select | Gene | Cds | Cds_length | GC_content | Pep | Pep_length |
|---|---|---|---|---|---|---|
| Accr1g02859 | ATGGAGTTTGCCACGTCAAGCTCCAATTTTGTCTCTGTTTTCTTCTCTGGATTTCTGCTTCTCTGTTTCTTCACTGTTTCTCCTTCAAACGCTCAACTTATACCCCAGGATGAAGTGAAGGCACTACAGGCAATATCAGATAAACTCACAAATGTGAATTGGAAGGTGACACAAACATCTTGTAGGACAGGGCTTGGATTTAATAACTTCACTCAATCTACTGGAATCACCAGGAATGTAACTTGCGATTGCACTTTCCAAAATGGCACCGTTTGCCATGTCACCCATATTCAGTTGAAAGGCCAGAATATAGCCGGACAAATACTCAGTGAATTTGGAAATCTTACCCAACTGACTGAGCTTGATCTCACTCGCAACTATCTCAATGGCACAATCCCAACAACAGTTTTTACCCGCATCCCTCTTGTCACTCTGTCACTTTTGGGGAATCGCATCAGTGGTCCAATTCCCGCAGAATTGGGTGAAATTGCTACTCTGCAGGAGCTGGTCTTGGAAGATAATCAGCTTGAAGGACGTCTTCCTCCGAGTCTTGGAAATTTGAGCAACCTACGGAGACTACTTCTTTCTGCAAATAATTTTACCGGGACAATACCAGAAACGTTTGGAAATCTAAAGAACCTAACTGATTTTAGGATAGATGGAAGCAGTTTATCAGGGAAGATACCTAATTTTATTGGGAACTGGACCAAAATTACTATCCTGAATATGCAGGGCACAGGCATGGAAGGTCCAATTCCTTCCAACATATCGTTGCTGACAAATTTGGAAGAATTGAGAATATCGGACTTGAGTGGAACAACCAACATGACATTTCCTAATCTAAAGGATTTGAAGATTTTGGAAATACTGATATTGAGAAATTGTCGAATTGTTGGTCCCATTCCTGATGACTTTGGACAAATGACAAGTTTAAAGACTCTAGACTTGAGTTTTAACATGTTGAATGGTTCAATCCCTCCTTCATTGGACTTGAAATCATTTAATCACATGTTTCTGACAAACAATTCTTTGAGTGGAGAAATTCCAGAGTGGATGATAGCAAGCAAACAAAATATTGATTTATCTTACAACAATTTTAGTGGGACTTCTGCAACTAGTTGCCAAGAAATCAATGTGAACCTGGCTTCTAGTCTCTCATCCTCTGCAAGTAATTCACTCTCCTGTTTGAAGAAGGGTCTACGTTGTGAGGGAAACCCAAAACAGCATTCGTTGTTCTTAAACTGTGGAGGAGACGAGATTGAGTTTGAAGGTCATGTATATGAACCAGATTTAACTCGAAATGGCATTTCATACTCTACTTTTAACCTTCATGACAACTGGGCTTATAGCAGCACAGGACTATATATGGGTAATGATAGTGCTGATTTTGTCGCAACAAATTCATCTCCATTGAATGCCAGTATCCCAGAATACTACCAAACCGCTCGCCTTAGCCCTCTATCCCTTAAGTACTATGGCCTATGCATGATGAGGGGCAATTATAATGTAAAGCTCCATTTTGCTGAGATAATGTTTTCTGATGACCAGACATATAGTAGCCTTGGTGTGCGCATATTTGATGTTTCAATTCAAGGTATCAAATACTTGGAAGATTTTAACATTGCAGAGAAAGCAGGTGGAGTTGGTAAGGGCATTACTATGGAATATGATGTTGATGTGAATGATGGAACCTTGGAGATCCATTTGTACTGGGCAGGGAAAGGAACTAATGCAATTCCCACTAGAGGTGTATATGGACCCCTAATATCTGCTATTACTGTGACCCCAAACTTCAAAATTCCTTCAAAAGGGTTGTCCACTGGAGCTATTGTTGGAATTGTGGTTGGATCATGTGTTTTCCTCGCATTGGTACTCATTATCCTCCGAAAGAAGGGTTTCCTTGGTGGGCAAGATCCAAAGGACAGAGAACTTTTAGATCTTAAGACAGGTTATTTTTCTCTAAGACAAATTAAAACAGCCACCAATAACTTTGACCCAGCCAATAAGATCGGAGAAGGAGGATTTGGGCCTGTGTACAAGGGTGTGCTGTCAGATGGTGTAGTCATTGCTGTTAAGCAGCTCTCTTCCAAGTCAAAACAAGGGAATCGAGAATTTGTTAATGAGATAGGAATGATTTCTGCATTGCAGCATCCGAATCTTGTGAAGCTTTATGGCTGTTGCATAGATGGAAATCAACTGATGCTTATATATGAATACATGGAGAACAATTGTCTTGCTCGAGCACTTTTTGGCCGTGAAGAACAGATGATACACTTGGATTGGCCCACAAGATTGAAGATTTGTCAGGGGATAGCAAGGGGGTTAGCTCATCTTCATGAGGAGTCAAGATTGAAAATAGTACATAGAGACATTAAGGCAACAAACATCTTACTTGATAAGGATCTAAATGCTAAAATTTCTGACTTCGGTTTAGCAAAGCTTGATGAAGAAGAGAATACACATATCAGCACCCGAATAGCTGGAACAATTGGTTACATGGCTCCTGAATATGCAATGAGAGGTTATTTGACAGACAAAGCAGATGTTTATAGCTTTGGAGTCGTCATTTTGGAGATTGTTAGCGGAAAGAACAACATGAATTATCGGCCAAAGGATGAGTTTGTTCATCTTCTTGATTGGGCCTATGTTCTCCAAGAGCAGGGAAACCTTTTAGAACTAGTGGATCCGCGTCTTGGTTCAAGATACTCTCAAGAAGAGGCCATGAGAATGCTCAACTTGGCTCTTTTGTGCACCAACCCATCTCCCTCCCTCAGACCAGCCATGTCATCTATAGTGAGCATGCTTGAGGGAAAAATGCCAATTCAAGCTCCAATAATCAAGCGCAAGGATTCAAGCCTGGATCAGCAGGATGCAAGGTTCAAAGCCTTGGAGATGCTATCACATGACAGCCAGACGTCTTTGGCCTCTCAAGTGAGTATTGAGCAAAGAGGCAATTCAATGGATGGACCATGGATTGATTCCTCAATATCTCTTCCTAGTGGAGATGATTATTCTTCATCTAGAAGACTTCTTTGA | 3036 | 0.4091 | MEFATSSSNFVSVFFSGFLLLCFFTVSPSNAQLIPQDEVKALQAISDKLTNVNWKVTQTSCRTGLGFNNFTQSTGITRNVTCDCTFQNGTVCHVTHIQLKGQNIAGQILSEFGNLTQLTELDLTRNYLNGTIPTTVFTRIPLVTLSLLGNRISGPIPAELGEIATLQELVLEDNQLEGRLPPSLGNLSNLRRLLLSANNFTGTIPETFGNLKNLTDFRIDGSSLSGKIPNFIGNWTKITILNMQGTGMEGPIPSNISLLTNLEELRISDLSGTTNMTFPNLKDLKILEILILRNCRIVGPIPDDFGQMTSLKTLDLSFNMLNGSIPPSLDLKSFNHMFLTNNSLSGEIPEWMIASKQNIDLSYNNFSGTSATSCQEINVNLASSLSSSASNSLSCLKKGLRCEGNPKQHSLFLNCGGDEIEFEGHVYEPDLTRNGISYSTFNLHDNWAYSSTGLYMGNDSADFVATNSSPLNASIPEYYQTARLSPLSLKYYGLCMMRGNYNVKLHFAEIMFSDDQTYSSLGVRIFDVSIQGIKYLEDFNIAEKAGGVGKGITMEYDVDVNDGTLEIHLYWAGKGTNAIPTRGVYGPLISAITVTPNFKIPSKGLSTGAIVGIVVGSCVFLALVLIILRKKGFLGGQDPKDRELLDLKTGYFSLRQIKTATNNFDPANKIGEGGFGPVYKGVLSDGVVIAVKQLSSKSKQGNREFVNEIGMISALQHPNLVKLYGCCIDGNQLMLIYEYMENNCLARALFGREEQMIHLDWPTRLKICQGIARGLAHLHEESRLKIVHRDIKATNILLDKDLNAKISDFGLAKLDEEENTHISTRIAGTIGYMAPEYAMRGYLTDKADVYSFGVVILEIVSGKNNMNYRPKDEFVHLLDWAYVLQEQGNLLELVDPRLGSRYSQEEAMRMLNLALLCTNPSPSLRPAMSSIVSMLEGKMPIQAPIIKRKDSSLDQQDARFKALEMLSHDSQTSLASQVSIEQRGNSMDGPWIDSSISLPSGDDYSSSRRLL | 1011 |
| Select | Seq ID | Length | Analysis | Description | Start | End | IPR | GO |
|---|---|---|---|---|---|---|---|---|
| Accr1g02859 | 1011 | Gene3D | Phosphorylase Kinase; domain 1 | 636 | 739 | - | - | |
| Accr1g02859 | 1011 | Gene3D | Transferase(Phosphotransferase) domain 1 | 740 | 949 | - | - | |
| Accr1g02859 | 1011 | SMART | LRR_typ_2 | 115 | 139 | IPR003591 | - | |
| Accr1g02859 | 1011 | SMART | LRR_typ_2 | 308 | 332 | IPR003591 | - | |
| Accr1g02859 | 1011 | SMART | LRR_typ_2 | 187 | 210 | IPR003591 | - | |
| Accr1g02859 | 1011 | FunFam | Putative LRR receptor-like serine/threonine-protein kinase isoform A | 204 | 271 | - | - | |
| Accr1g02859 | 1011 | FunFam | Probable LRR receptor-like serine/threonine-protein kinase At1g53440 | 38 | 203 | - | - | |
| Accr1g02859 | 1011 | FunFam | LRR receptor-like serine/threonine-protein kinase ERECTA | 278 | 369 | - | - | |
| Accr1g02859 | 1011 | FunFam | Putative leucine-rich repeat receptor-like serine/threonine-protein kinase | 408 | 597 | - | - | |
| Accr1g02859 | 1011 | PANTHER | LEUCINE-RICH REPEAT-CONTAINING PROTEIN DDB_G0281931-RELATED | 18 | 970 | - | - | |
| Accr1g02859 | 1011 | SUPERFAMILY | Protein kinase-like (PK-like) | 649 | 944 | IPR011009 | - | |
| Accr1g02859 | 1011 | FunFam | probable LRR receptor-like serine/threonine-protein kinase At1g53430 | 636 | 739 | - | - | |
| Accr1g02859 | 1011 | Pfam | Malectin domain | 411 | 592 | IPR021720 | - | |
| Accr1g02859 | 1011 | ProSiteProfiles | Protein kinase domain profile. | 664 | 946 | IPR000719 | GO:0004672|GO:0005524|GO:0006468 | |
| Accr1g02859 | 1011 | ProSiteProfiles | Leucine-rich repeat profile. | 310 | 332 | IPR001611 | GO:0005515 | |
| Accr1g02859 | 1011 | MobiDBLite | consensus disorder prediction | 991 | 1011 | - | - | |
| Accr1g02859 | 1011 | Gene3D | Ribonuclease Inhibitor | 203 | 272 | IPR032675 | - | |
| Accr1g02859 | 1011 | Gene3D | - | 407 | 597 | - | - | |
| Accr1g02859 | 1011 | FunFam | Putative LRR receptor-like serine/threonine-protein kinase | 740 | 947 | - | - | |
| Accr1g02859 | 1011 | ProSitePatterns | Serine/Threonine protein kinases active-site signature. | 786 | 798 | IPR008271 | GO:0004672|GO:0006468 | |
| Accr1g02859 | 1011 | SMART | serkin_6 | 664 | 933 | IPR000719 | GO:0004672|GO:0005524|GO:0006468 | |
| Accr1g02859 | 1011 | Gene3D | Ribonuclease Inhibitor | 37 | 202 | IPR032675 | - | |
| Accr1g02859 | 1011 | Gene3D | Ribonuclease Inhibitor | 273 | 386 | IPR032675 | - | |
| Accr1g02859 | 1011 | Pfam | Protein tyrosine and serine/threonine kinase | 668 | 935 | IPR001245 | GO:0004672|GO:0006468 | |
| Accr1g02859 | 1011 | CDD | STKc_IRAK | 670 | 937 | - | - | |
| Accr1g02859 | 1011 | SUPERFAMILY | L domain-like | 84 | 368 | - | - |
| Select | Gene | Chromosome | Start | End | Duplicated_type |
|---|---|---|---|---|---|
| Accr1g02859 | Accr-Chr1 | 65584636 | 65593624 | Dispersed/Tandem |
| Select | Gene | Gene_start | Gene_end | Function | Ath_gene | Identity(%) | E-value | Score |
|---|---|---|---|---|---|---|---|---|
| Accr1g02859 | 14 | 1002 | Receptor kinase-like Gene Family | AT1G53440 | 62.537 | 0.0 | 1240 |
| Select | Regulatory Factors | Family | Gene | Hmm_acc | Hmm_name | E_value | Clan |
|---|---|---|---|---|---|---|---|
| PK | RLK-Pelle_DLSV | Accr1g02859 | PK_Tyr_Ser-Thr | 5.6e-50 | CL0016 |
| Select | Query | KO | Definition | Second KO | KEGG Genes ID | GHOSTX Score |
|---|---|---|---|---|---|---|
| Accr1g02859 | - | - | gmx:100815226 | 1389.02 |